GP access to body CT for suspected malignancy

Slides:



Advertisements
Similar presentations
Lung Pathway updated 21/5/10 Dr Woolhouse 1 GP refers patient. CXR suspicious for lung cancer? Report sent to GP. No further action. Report using X15 code.
Advertisements

The Thyroid Incidentaloma
Audit of Impact of NICE guidelines for Ovarian Cancer Helen Losty Royal United Hospital Bath 17th November 2011.
By Dr Varuna Paranahewa
Matthew Kilmurry, M.D. St. Mary’s General Hospital Grand River Hospital.
Metastatic involvement (M) M0 - No metastases M1 - Metastases present.
Dr Andrea J Howes Consultant Radiologist St Helens and Knowsley NHS Trust.
Background The 2 week wait referral system was designed to expedite the referral of patients, suspected to have cancer, from Primary to Secondary care.
Scottish Clinical Imaging Network 30/4/15 Direct Access to Cross Sectional Imaging for General Practitioners.
Metastatic Spinal Cord Compression
How to manage suspected cancer
Right shoulder and chest pain Kate Rubey November 2013.
Department of General Practice Aarhus University Diagnostic delay in cancer in primary health care Before and after introducing urgent referrals for suspected.
‘Let’s get it right - Referral for suspected Cancer’
Radiology “Dos and Don’ts” Clinical Governance Medical Division 18 July 2013.
Summary The National Clinical Pathway represents a pathway that is achievable now, requiring no extra resources but reliant on appropriate logistics. The.
The One Stop Head and Neck Lump Clinic David Courtney Consultant Maxillofacial Surgeon Derriford Hospital, Plymouth.
Consultant Obstetrician & Gynaecologist
ONE YEAR EXPERIENCE OF A “ SAFETY NET” PROTOCOL FOR ABNORMAL CHEST RADIOGRAPHS (CXR) H Singh, SCO Taggart, PM Turkington, K Peplow, R Chisholm, BR O’ Driscoll.
Outcomes Following Urgent Referral for Head & Neck Ultrasound Dr Anna ffrench-Constant Dr Mandy Williams.
Macmillan Ipswich Diagnostic Assessment Service (MIDAS)
National Optimal Clinical Pathway for suspected and confirmed lung cancer: Referral to treatment Note: this was previously circulated for discussion as.
FIT Programme (Faecal Immunohistochemical Test)
Implementation of a lung health clinic in high-risk individuals in South East London: a prospective feasibility cohort study Background In 2013, lung cancer.
National Clinical Pathway for suspected and confirmed lung cancer:
Guidelines for Communication & Reporting
Refer to Beds & Herts Breast Cancer Family History Screening service
Lothian Heart Failure Diagnostic Pathway
HIV acutely unwell pathway Sussex HIV Network This pathway applies to all patients other than those listed in non-acute pathway All HIV+ patients with.
MOTOR NEURONE DISEASE IN THE EMERGENCY DEPARTMENT
Cancer Audit Stourport Health Centre Feb 2016
Choosing Wisely : Radiology Perspective
Anticipatory Health Care Calendar Learning Disabilities.
EOL care Closing the Gap 2b.
No age(‘s) disease days Medical fee Nursing fee Transportation fee
Radio Iodine Therapy In Cancer Thyroid
SWAG Cancer Alliance Update
Quality of Referrals Guideline Congruence of referrals to TIAMS clinic
Male and Female Reproductive Health Concerns
PSO – Paper Switch Off Project
Recognition and Referral of Suspected cancer NICE NG12 – 2Week Wait
Study of Head and Neck Cancer two-week wait referral pathway
Dorset County Hospital Cancer of Unknown Primary (CUP) Service
Process for establishing the Patient Reference
Lung Cancer Screening:
Applications of Diagnostic Imaging Computed Tomography
Dr James Carlton, Medical Adviser
Applications of Diagnostic Imaging Nuclear Medicine
AN OVERVIEW OF THE BONE METASTASES PROGRAM
Repeat fasting lipid profile to confirm in 1-2 weeks
Refer to Beds & Herts Breast Cancer Family History Screening service
Dr T P E Wells 13 July 2018 Breast SSG Bath
Lung Cancer Pathways: Interim Report
Lung Cancer Screening Sandra Starnes, MD Professor of Surgery
Lung Cancer Pathway Dr Heather Harris - Consultant Radiologist
Alcohol Related Liver Disease Pathway
Dr Rajayogeswaran Dr Mike Bradley
Lothian Heart Failure Diagnostic Pathway
Solitary Thyroid Nodule Aisha Abu Rashed
General Imaging Information
NHS South Tees CCG Rapid Specialist Opinion (RSO)
Calculate Well’s score for PE (BOX1)
Ambulatory Safety Nets: Creating High-Reliability Solutions to Prevent Missed and Delayed Diagnoses Sonali Desai, MD, MPH April 3, 2019.
Advice & guidance.
Airedale NHS Foundation Trust
Calderdale and Huddersfield NHS Foundation Trust
Direct Access CT Lung Pathway V3 Updated 13/06/2016
Patients referred under UGI 2WW
NHS Long Term Plan: Rapid Diagnostic Centres (RDC) The SWAG Approach
Urology cancer update for primary care
Presentation transcript:

GP access to body CT for suspected malignancy Pilot audit results Dr Allan Green/Dr Stephen Glancy, Radiology, NHS Lothian

Referrals 28 referrals 1 patient refused scan; 1 request was actually for CT brain; 1 should have been an Ultrasound 25 CT Chest, Abdomen and Pelvis scans performed 88% (22/25) referrals appropriate for pathway, 12% (3/25) should have been arranged by secondary care. 100% (25/25) appropriate for CT scanning

Referral to Scan Mean time from referral to scan 21 days Two graphs

Patients Mean age 70.8 12 Male 13 Female Practice referred total number

Cancer pickup 24% (6/25) definite cancers 5% (1/25) possible cancer 2 Lung 2 Pancreas 1 Renal 1 Cervical 5% (1/25) possible cancer 1 Lung

Other findings Overall (14/28) 50% 1 Renal calculi 1 PE 2 Pneumonia 2 Hydronephrosis 1 Rib fractures 2 Vertebral fractures 1 Cirrhosis 1 Asbestos lung disease 1 Pancreatic cysts 1 Pulmonary nodule 1 Lung scarring

Referral to secondary care 20% (5/25) of patients scanned did not then require a secondary care referral

Further tests 25 Patients scanned 6 Cancer 1 probable 18 No cancer 13 Referred to secondary care 4 Follow up imaging 9 No follow up imaging 5 Not referred to secondary care Further tests

Summary Appropriate referrals Significant detection rate of cancers Significant reduction in referral to secondary care Significant relevant non cancer findings Education on using appropriate pathways Potential to significantly streamline the cancer pathway

FAQs How do I refer a patient for CT with a suspected malignancy? Refer to Guidance on RefHelp (URL...) Via SCI Gateway (URL...) What do I do if the CT I request reveals a malignancy? Refer as urgent to the appropriate specialty as normal. If the primary source is unclear, refer to the Cancer of Unknown Primary (CUP) Team or contact CUPTeam@nhslothian.scot.nhs.uk to discuss What do I do if there is an ‘incidental’ finding on the CT? The report will often guide the referrer as to the most appropriate next step; often no action is required. Specific advice may be available on RefHelp. The reporting radiologist will also be able to advise on specific findings and is happy to be contacted. Renal or hepatic cysts do not generally merit any follow-up unless advised Atelectasis, tiny pulmonary nodules, sub-cm nodes, diverticular disease, bony haemangiomas and Tarlov’s cysts are usually incidental findings How do I contact the reporting radiologist? NHS email is usually the easiest way to communicate. The duty radiologist in each department will also be available for advice. What if the patient has a CXR suspicious of malignancy? These patients should NOT be on the Vague Symptoms Pathway. There is an established Fast Track Suspected Lung Cancer Pathway at WGH (LCCWGH@nhslothian.scot.nhs.uk) , SJH (SJH.Respiratory@nhslothian.scot.nhs.uk ) and RIE (0131 242 1867) What if I request an US which shows suspected liver metastases, but no obvious primary? These patients should NOT be on the Vague Symptoms Pathway. Sometimes the Radiology department will arrange further imaging or suggest the appropriate next step. The CUP team are happy to be referred these patients (CUPTeam@nhslothian.scot.nhs.uk).